%0 Journal Article
%T Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
%A Masahito Ohji
%A Sanae Muraki
%A Tomoaki Higashiyama
%J Archive of "Case Reports in Ophthalmology".
%D 2017
%R 10.1159/000461575
%X Laser therapy has been the gold standard treatment for retinopathy of prematurity (ROP), while intravitreal bevacizumab (IVB) is reported to be of significant benefit for zone I ROP. A problem with laser therapy is that it is difficult to administer in ROP patients with severely dilated tunica vasculosa lentis and poor mydriasis. However, although IVB treatment has been performed in such severe ROP cases, only 1 report has discussed its usefulness
%K Retinopathy of prematurity
%K Intravitreal bevacizumab
%K Laser therapy
%K Tunica vasculosa lentis
%K Mydriasis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465726/